Search
A pooled analysis was conducted of 1,257 toddlers who received a fourth dose of Haemophilus influenzae type b- Neisseria meningitidis serogroups C and...
Unambiguous identification of nontypeable Haemophilus influenzae (NTHi) is not possible by conventional microbiology. Molecular characterisation of...
In Australia the 7-valent pneumococcal conjugate vaccine (PCV7) is administered at 2, 4 and 6 months of age, with no booster dose.
Increased numbers of children presenting with febrile adverse events following trivalent influenza vaccine (TIV) were noted in Australia in 2010.
Males are generally more susceptible to respiratory infections; however, there are few data on the physiological responses to such infections in males and...
Influenza is major cause of paediatric hospitalisation. Influenza vaccine was offered to all children aged 6-59 months resident in Western Australia in 2008
How Influenza outbreaks during mass gatherings have been rarely described, and detailed virologic assessment is lacking.
This study aimed to determine whether chronic, low-dose exposure to geogenic particulate matter <10μm diameter (PM10) exacerbates viral infections of the...
This paper reports the results from the safety surveillance of influenza vaccines in children in Australia, in 2015.
This study was designed to compare data collected via SMS and telephone for the purposes of monitoring vaccine safety.